ACTN4 amplification is frequently observed in patients with carcinomas of the pancreas, ovary, lung, and salivary gland, and patients with ACTN4 amplifications have worse outcomes than patients without amplification. The gene discussed is ACTN4; the disease is exocrine pancreatic carcinoma.